Balanced news tone
News Sentiment
LLY sentiment intelligence
Eli Lilly and Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
55
Balanced news tone
22 relevant articles
News tone and price action are not far from neutral.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-3.8% over one week, +6.6% over four weeks, trend inactive, and materially above fair value.
Eli Lilly (LLY) Receives Approval for Centessa Acquisition Deal
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
86/100 classification
One-week reaction
-3.8%
Price reacting lower
Trend fit
Trend inactive
6.6% over four weeks
Fair value
31.9%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
8
Neutral
12
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
GuruFocus
Direct company coverage
Eli Lilly (LLY) Receives Approval for Centessa Acquisition Deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Jun 2026 22:13
- Source
- GuruFocus
TradingView
Direct company coverage
Eli Lilly Declares Q3 2026 Dividend Of $1.73 Per Share
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 22 Jun 2026 15:20
- Source
- TradingView
Insider Monkey
Direct company coverage
Is Eli Lilly and Company (LLY) among the Best Longevity and Anti-Aging Stocks to Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 13:13
- Source
- Insider Monkey
ChartMill
Direct company coverage
Eli Lilly & Co. (NYSE:LLY): A High-Growth Champion Aligned with Navellier's Proven Strategy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 11:10
- Source
- ChartMill
simplywall.st
Direct company coverage
Eli Lilly (LLY) Teams Up With BioArctic On A New Neurodegeneration Therapy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 08:26
- Source
- simplywall.st
Market source
Direct company coverage
Eli Lilly (LLY) Stock After 45% Yearly Gain Is The Valuation Still Justified
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Jun 2026 23:08
- Source
- Market source
AD HOC NEWS
Direct company coverage
Eli Lilly Stock - Analyst consensus stays bullish on weight-loss boom
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 20 Jun 2026 18:25
- Source
- AD HOC NEWS
Quiver Quantitative
Direct company coverage
Eli Lilly Stock (LLY) Opinions on Pipeline Expansions and Regulatory Risks
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 20 Jun 2026 17:33
- Source
- Quiver Quantitative
ChartMill
Direct company coverage
Eli Lilly & Co (NYSE:LLY): A Dividend Growth Gem with Strong Fundamentals
- Tone
- Positive 82/100
- Event
- Capital return
- Published
- 19 Jun 2026 11:10
- Source
- ChartMill
Market source
Direct company coverage
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 18 Jun 2026 21:45
- Source
- Market source
Investor's Business Daily
Direct company coverage
Booking A Quick Gain In Eli Lilly Avoided Market Turbulence
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 18 Jun 2026 20:29
- Source
- Investor's Business Daily
Market source
Direct company coverage
Eli Lilly (LLY) Stock Could Be 24.7% Undervalued on Its Growth Narrative
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 18 Jun 2026 18:15
- Source
- Market source
Trefis
Direct company coverage
Eli Lilly Stock’s Trillion-Dollar Question
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 18:20
- Source
- Trefis
simplywall.st
Direct company coverage
Eli Lilly (LLY) Stock After Huge GLP 1 Expectations And 7x Five Year Run
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 16:38
- Source
- simplywall.st
Trefis
Direct company coverage
Everyone Is Watching Eli Lilly Stock’s New Drugs. Here Is the Metric That Vanished
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 15:57
- Source
- Trefis
Market source
Direct company coverage
Why Eli Lilly (LLY) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Why Eli Lilly (LLY) Stock Is Trading Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Market source
AD HOC NEWS
Direct company coverage
Eli Lilly & Co. stock (US5324571083): Q1 revenues surge 56% on obesity drug boom
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- AD HOC NEWS
Barron's
Direct company coverage
Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- Barron's
AskTraders
Direct company coverage
Eli Lilly Stock Price (LLY) Holding On To $1000 Ahead of Earnings – What Next?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Feb 2026 08:00
- Source
- AskTraders
Reuters
Direct company coverage
Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 27 Jan 2026 08:00
- Source
- Reuters
BioProcess International
Direct company coverage
Eli Lilly talks Trump's tariffs as biotechnology and biopharma stocks sink
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Apr 2025 07:00
- Source
- BioProcess International